Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $398.88 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2026-08-03
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $398.88M.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $458.19M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $212.24M.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $214.01M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five as first filed |
|---|---|---|
| 2026-06-30 | $398.88M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $458.19M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $212.24M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $214.01M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $294.21M 10-Q · filed 2025-08-07 | |
| 2024-12-31 | $467.36M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $448.85M 10-Q · filed 2025-05-08 | $119.12M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $116.17M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $45.90M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $467.36M 10-Q · filed 2025-05-08 | $89.25M 10-K · filed 2024-02-28 |
| 2023-09-30 | $120.61M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $482.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $26.64M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $58.21M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $86.48M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $112.49M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $84.37M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $101.93M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $18.31M 10-K · filed 2022-03-30 |